JANX
Janux Therapeutics Inc
16.30$
-2.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -465.2% | -402.3% | -1,185.1% | -112.6% | -508.2% | – | – | – | -128.6% | -362.2% | -330.5% | 1.4% | -168.1% | |
| 19.9% | 21.6% | 42.5% | 5.7% | 116.2% | – | – | – | 5.0% | 5.9% | 12.6% | 9.1% | 7.4% | |
| 180.7% | 182.2% | 449.3% | 64.7% | 3,505.0% | – | – | – | 90.4% | 120.7% | 248.3% | 178.5% | 144.8% | |
| -122.4% | -44.5% | -355.2% | -82.6% | 2,922.3% | – | – | – | 65.4% | -38.8% | 131.5% | 318.8% | 129.0% | |
| 18.7% | 20.9% | 15.7% | 1.1% | 5.7% | – | – | – | 0.9% | 1.3% | 7.3% | 4.6% | 3.0% | |
| -2,441.4% | 452.0% | -9,084.3% | -2,145.5% | 2,887.0% | – | – | – | 83.1% | 374.9% | 222.0% | -297.0% | 49.0% | |
| – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 2,249.1% | 33.8% | 25,732.5% | 31.1% | 375.6% | – | – | – | 4.9% | 37.4% | 95.0% | 56.3% | 40.0% | |
| -657.6% | 83.4% | 15,463.1% | -2,227.1% | 2,754.4% | – | – | – | -40.6% | 50.1% | -13.6% | -239.3% | -79.0% | |
| -483.9% | -423.2% | -1,200.8% | -113.7% | -513.9% | – | – | – | -129.5% | -363.6% | -337.8% | -3.2% | -171.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.